S617-0900 Screening compound: N-{1-[(2,4-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl}benzamide

S617-0900 Screening compound: N-{1-[(2,4-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl}benzamide
S617-0900 Screening compound: N-{1-[(2,4-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S617-0900
N-{1-[(2,4-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S617-0900

Molecular Formula

C20H22F2N2O2 (C20 H22 F2 N2 O2)

Compound Name

N-{1-[(2,4-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl}benzamide

IUPAC name

N-[(3S4S)-1-[(24-difluorophenyl)methyl]-4-(hydroxymethyl)piperidin-3-yl]benzamide

SMILES

OC[C@H](CCN(Cc(ccc(F)c1)c1F)C1)[C@H]1NC(c1ccccc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

360.4

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.427

Distribution Coefficient, logD

2.408

Water Solubility, LogSw

-2.72

Polar Surface Area

45.356

Acid Dissociation Constant (pKa)

13.51

Base Dissociation Constant (pKb)

6.04

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.00

S617-0900 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S617-0900 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S617-0900?
Check Price and Availability of S617-0900, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S617-0900 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S617-0900
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S617-0900
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S617-0900 available by request